|
Fund Overview
Quote
Performance
|
Chart
Charting
Compare to:
UPDATE 1-Cephalon gets subpoena from U.S. DOJ
September 30, 2011
|
Top News
More News
REFILE-UPDATE 1-Valeant offers C$88 mln for Afexa, tops Paladin
September 26, 2011
Valeant to offer C$88 mln for Afexa, tops Paladin
September 26, 2011
EU mergers and takeovers (Sept 23)
September 23, 2011
Teva offers EU watchdog concessions for Cephalon buy
September 23, 2011
Cephalon sues Sandoz over Fentora cancer drug
September 16, 2011
EU mergers and takeovers (Sept 16)
September 16, 2011
EU mergers and takeovers (Sept 14)
September 14, 2011
UPDATE 2-Valeant tops Paladin with C$76 mln bid for Afexa
August 30, 2011
EU mergers and takeovers (Aug 29)
August 29, 2011
UPDATE 3-Generic threat to Valeant drug sends shares reeling
August 04, 2011
UPDATE 1-Cephalon quarterly profit falls short of estimates
August 02, 2011
UPDATE 5-Meda shares jump on Valeant bid speculation
July 27, 2011
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here